Mustafa Mohammad, MD
Dermatopathology · Tampa, FLNPI 1598183659
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 142 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 25.6% of the total. Reporting peaked in 2020 at $570 and has fallen 50.6% since, to $282 in 2025. Among dermatopathology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 142 payments — averaging $19.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$716
- Lilly USA, LLC$265
- Sanofi$250
- Regeneron Healthcare Solutions, Inc.$240
- Sun Pharmaceutical Industries Inc.$225
- Mayne Pharma Commercial LLC$196
- plus $901 from 12 others
What the payments were for
- Food & beverage$2,792100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 45 | $716 |
| Lilly USA, LLC | 12 | $265 |
| Sanofi | 12 | $250 |
| Regeneron Healthcare Solutions, Inc. | 9 | $240 |
| Sun Pharmaceutical Industries Inc. | 11 | $225 |
| Mayne Pharma Commercial LLC | 12 | $196 |
| Amgen | 8 | $145 |
| Boehringer Ingelheim | 5 | $114 |
| UCB, Inc. | 4 | $114 |
| Biofrontera Inc. | 5 | $96 |
| Stemline Therapeutics Inc. | 1 | $94 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $79 |
| Almirall LLC | 3 | $70 |
| LEO Pharma Inc. | 3 | $56 |
| Johnson & Johnson | 3 | $52 |
| Myriad Genetic Laboratories, Inc. | 2 | $35 |
| Incyte Corporation | 1 | $24 |
| Scpharmaceuticals Inc. | 1 | $23 |
How this compares
$2,792 in reported general payments places this provider in the 90th percentile of 62 dermatopathology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatopathology in Tampa
- John MillnsTampa$8K
- Sairekha RavichandranTampa$1K
- Lewis GlassTampa$803
- William EngTampa$767
- Hugh StoddardTampa$525
- Rachel CarecciaTampa$411
- Wei-Shen ChenTampa$397
- Mary ParisiTampa$218
- Paul Rodriguez-WaitkusTampa$192
- Manojkumar PatelTampa$122
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.